Expression of XPG protein in the development, progression and prognosis of gastric cancer

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Deng, Na ^a   Liu, Jing Wei ^a   Sun, Li Ping ^a   Xu, Qian ^a   Duan, Zhi Peng ^a   Dong, Nan Nan ^a   Yuan, ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEASE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP G PROTEIN;

ADULT; AGE; ARTICLE; ATROPHIC GASTRITIS; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SMOKING; STOMACH CANCER; SUPERFICIAL GASTRITIS; TUMOR INVASION; AGED; CANCER STAGING; COMPLICATION; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH MUCOSA; STOMACH NEOPLASMS; SURVIVAL; XERODERMA PIGMENTOSUM;

AGE FACTORS; AGED; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SEX FACTORS; SMOKING; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; XERODERMA PIGMENTOSUM;

EID: 84907546620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108704     Document Type: Article

References (32)

1. Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477.
2. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World I Gastroenterol 12: 354-362.
3. Iyama T, Wilson DM 3rd (2013) DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) 12: 620-636.
4. Halliwell B. Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85.
5. Charames GS, Bapat B (2003) Genomic instability and cancer. Curr Mol Med 3:589-596.
6. Kim IJ, Ku JL, Kang HC, Park JH, Yoon KA, et al. (2004) Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients. Hum Genet 115: 498-503.
7. Kuraoka I, Bender C, Romieu A, Cadet J, Wood RD, et al. (2000) Removal of oxygen free-radical-induced 5,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc Natl Acad Sci U S A 97: 3832-3837.
8. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
9. Latimer JJ, Johnson JM, Kelly CM, Miles TD, Beaudry-Rodgers KA, et al. (2010) Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer. Proc Natl Acad Sci U S A 107: 21725-21730.
10. Costa RM, Chigancas V, Galhardo Rda S, Carvalho H, Menck CF (2003) The eukaryotic nucleotide excision repair pathway. Biochimie 85: 1083-1099.
11. Berneburg M, Lehmann AR (2001) Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 43: 71 -102.
12. Lehmann AR (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85: 1101-1 111.
13. Sugasawa K (2008) Xeroderma pigmentosum genes: functions inside and outside DNA repair. Carcinogenesis 29: 455-465.
14. Agarwal R, D'Souza T, Morin IJ (2005) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385.
15. Sabatino MA, Marabese M, Ganzinelli M, Caiola E, Geroni C, et al. (2010) Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells. Mol Cancer 9: 259.
16. Tomicic MT, Reischmann P, Rasenberger B, Meise R, Kaina B, et al. (2011) Delayed c-Fos activation in human cells triggers XPF induction and an adaptive response to UVC-induced DNA damage and cytotoxicity. Cell Mol Life Sci 68: 1785-1798.
17. Kamileri I, Karakasilioti I, Garinis GA (2012) Nucleotide excision repair: new tricks with old bricks. Trends Genet 28: 566-573.
18. Cheng L, Spitz MR, Hong WK, Wei Q (2000) Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 21: 1527-1530.
19. Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q (2002) Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94: 393-397.
20. Wei Q, Wang LE, Sturgis EM, Mao L (2005) Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 14: 1961 -1966.
21. Kovacs E, Stucki D, Weber W, Muller H (1986) Impaired DNA-repair synthesis in lymphocytes of breast cancer patients. Eur J Cancer Clin Oncol 22: 863-869.
22. Kovacs E, Almendral A (1987) Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer. Eur J Cancer Clin Oncol 23: 1051-1057.
23. Ramos JM, Ruiz A, Colen R, Lopez ID, Grossman L, et al. (2004) DNA repair and breast carcinoma susceptibility in women. Cancer 100: 1352-1357.
24. Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, et al. (2006) Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. Cell Oncol 28: 315-326.
25. Ganzinelli M, Mariani P, Cattaneo D, Fossati R, Fruscio R, et al. (2010) Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations. Eur J Cancer 47: 1086-1094.
26. Aracil M, Dauffenbach LM, Diez MM, Richeh R, Moneo V, et al. (2013) Expression of XPG protein in human normal and tumor tissues. Int J Clin Exp Pathol 6: 199-211.
27. Liu YP, Ling Y, Qi QF, Zhang YP, Zhang CS, et al. (2013) The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Oncol Lett 5: 935-942.
28. Jian-Wei B, Yi-Min M, Yu-Xia S, Shi-Qing L (2013) Expression levels of ERCC1 and RRM1 mRNA and clinical outcome of advanced non-small cell lung cancer. Pak J Med Sci 29: 1158-1161.
29. Bartolucci R, Wei J, Sanchez JJ, Perez-Roca L, Chaib I, et al. (2009) XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. Clin Lung Cancer 10: 47-52.
30. Schoffski P, Taron M, Jimeno J, Grosso F, Sanfilipio R, et al. (2011) Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study. Eur J Cancer 47: 1006-1012.
31. Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, et al. (2008) ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin Oncol 26: 2952-2958.
32. Vaezi A, Wang X, Buch S, Gooding W, Wang L, et al. (2011) XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res 17: 5513-5522.